FDA Inspection
Astellas Ireland Co., Ltd.Astellas Ireland Co., Ltd. – FDA Inspection, Feb 12, 2016
Record Details
This FDA Inspection record concerns Astellas Ireland Co., Ltd., with an inspection on February 12, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Astellas Ireland Co., Ltd.
- Inspection Date
- February 12, 2016
- Product Type
- Drugs
View Company Profile
ID · 6bb6b34e-6a5d-49f1-bc74-c35dda7e76bc
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 962296
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Astellas Ireland Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 17, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 17, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 19, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Astellas Ireland Co., Ltd.
- FDA Inspection 1271041 - 2022-06-17
- FDA Inspection 1127818 - 2020-01-17
- FDA Inspection 853359 - 2013-09-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.